Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome

Luiz Carlos Porcello Marrone; Bianca Fontana Marrone; Julia de la Puerta Raya; Giovani Gadonski; Jaderson Costa da Costa

doi:10.1159/000324581

Gemcitabine monotherapy associated with posterior reversible encephalopathy syndrome

Case Rep Oncol. 2011 Feb 16;4(1):82-7. doi: 10.1159/000324581.

Authors

Luiz Carlos Porcello Marrone¹, Bianca Fontana Marrone, Julia de la Puerta Raya, Giovani Gadonski, Jaderson Costa da Costa

Affiliation

¹ Instituto do Cérebro, Porto Alegre, Brazil.

Abstract

Posterior reversible encephalopathy syndrome is a clinicoradiologic entity that may present with headaches, altered mental status, seizures and visual loss as well as specific neuroimaging findings. We report a case of a 74-year-old woman receiving adjuvant gemcitabine chemotherapy as monotherapy for a stage IIa pancreatic adenocarcinoma, who developed posterior reversible encephalopathy syndrome.

Keywords: Chemotherapy; Gemcitabine; Posterior reversible encephalopathy syndrome.

Publication types

Case Reports